This article comes from Figaro Magazine
Strategically, one must know the enemy well in order to fight with him. So it is better to decode the genetic material of the tumor to destroy it better. “We can no longer just look at it with a microscope. Thanks genomic tests, we can now identify the genes that cause it, but also study their expression. The choice of treatment depends on this. if the tumor represents a genetic, inherited, or random abnormality, there is likely to be a targeted drug that is effective against this mutation. explains Professor Pascal Pujol, oncologist at the University Hospital of Montpellier, President of the French Society for Predictive and Personalized Medicine.
But doctors face a thorny problem. In university hospitals and cancer centers, management agrees to reimburse the cost of these tests only partially (about 50%), which can sometimes reach more than 2,200 euros. But it doesn’t have to be…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.